+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Direct-to-Consumer (DTC) Genetic Testing - Global Market Trajectory & Analytics

  • ID: 2255350
  • Report
  • July 2020
  • Region: Global
  • 327 Pages
  • Global Industry Analysts, Inc
COVID-19 Turbocharges Telemedicine & With it Remote Genetic & Genomic Consultant Services. DTC Genetic Testing to Reach $2.2 Billion

The global market for Direct-to-Consumer (DTC) Genetic Testing is projected to reach US$2.2 billion by the year 2027, trailing a CAGR of 11.5% over the analysis period 2020 through 2027. The pandemic has catalyzed telemedicine and encouraged adoption of newer models of remote care. Rising demand for telemedicine services holds a strong potential to push-up genetic counseling in community care centers. New studies reveal that over 55% of patients undergoing genetic counseling via videoconferencing are likely to undergo genetic testing. Growing incidence of cancer and rise in excess mortality due to COVID-19 induced disruptions in timely care will result in increased adoption of Direct-to-Consumer (DTC) genetic testing in the coming years. In addition to being cheap, DTC genetic testing also eliminates a clinical visit which is desirable in COVID-19 times.

Genetic testing kits, for in-home use provide the user with real-time information for determining genetic ancestry, identifying susceptibility to a particular disease, prediction of medical risks, response of the body to a particular drug, earlier detection of diseases, and better management of health. The concept of direct-to-consumer (DTC) genetic testing has undergone noteworthy changes since its availability in the mid-2000s. Some of the main spotlights in the market have been disruptions in pricing structure, emergence of new business models and availability of plethora of options. Favored by entry of various players and fierce competition along with technological advancements, prices of these genetic tests have plunged notably. Players such as Helix have taken cue from Apple and introduced app stores for genetic testing. The business model is embraced by various start-ups in the US and Europe. Some of the players are offering diet and fitness recommendations, tests for a specific disorder, and options to measure epigenetic, representing chemical modifications to the DNA correlating with factors like ageing and smoking. The substantial demand for these test kits has prompted various players to foray into the market and offer advanced products to gain share.

The market in the long-term will be driven by new advancements, increasing prevalence of various genetic disorders like Alzheimer's, cystic fibrosis and cancer. In addition, more than 300 million individuals globally are suffering from rare diseases. These cases create the need for genetic tests for timely detection of genetic diseases. Despite concerns regarding data privacy and validity of results, DTC genetic testing continues to garner significant attention among consumers and is anticipated to eventually collide with conventional healthcare systems. The growth of DTC genetic testing market will be facilitated by increasing adoption of personalized medicine for treating genetic diseases along with rising disposable income, healthcare expenditures and user awareness. A large number of people will be using these tests to get genetic information for analyzing genetic predisposition to various diseases. Other growth driving factors for the DTC genetic testing market include ageing population who display a tendency towards taking interest in their own healthcare, a fact compounded by the availability of genetic tests that can identify gene variations that enhance the risk of various old-age diseases, including Alzheimer's; decreasing cost of ordering DTC genetic tests; and the privacy and anonymity that the technology offers.

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Note: Product cover images may vary from those shown

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Genetic Testing: A Synopsis

Recent Market Activity

Direct-to-Consumer (DTC) Genetic Testing: An Overview

Major Factors Impacting DTC Genetic Testing Market

Regulatory Restrictions and Privacy Concerns - Major Dampeners for DTC Genetic Testing

Consumers Self-Managing Treatments: The New Trend

Authorities Grappling With Setting Appropriate Regulations for DTC Genetic Testing

Changing Landscape of DTC Genetic Testing

Regulations to Determine Market Viability

Potential Benefits Outweigh Concerns

DTC Genetic Testing: High Potential Benefits, But Concerns Persist

Quality Assurance

Confidentiality of Genetic Information

Price and Related Services

Greater Chances of Misinterpretation

Regulatory Headwinds and Data Paucity Impacting DTC Genetic Testing Market

Despite Progress in DTC Genetic Testing Regulations, Concerns Still Linger

Transparency of Data: Bugbear of DTC Genetic Testing Companies

The Contextual Privacy Conundrum

Increasing Adoption Raises the Threat of Data Breach

DTC Genetic Testing Companies - An Unregulated Lot

Association for Molecular Pathology v. Myriad Genetics, Inc. Ruling Removes Potential Barriers for DTC Genetic Testing Companies

Competitive Scenario

Recent Transactions in DTC Genetics Testing Market

Global Competitor Market Shares

Direct-to-Consumer (DTC) Genetic Testing Competitor Market Share Scenario Worldwide (in %): 2020 & 2029

Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

23andMe, Inc. (USA)

Ancestry.com, LLC (USA)

Any Lab Test Now (USA)

Color Genomics, Inc. (USA)

Counsyl, Inc. (USA)

Direct Laboratory Services, LLC (USA)

Gene by Gene, Ltd. (USA)

Laboratory Corporation of America® Holdings (USA)

Mapmygenome India Limited (India)

Positive Bioscience, Inc. (India)

Quest Diagnostics, Inc. (USA)

Request A Test, Ltd. (USA)

Sonora Quest Laboratories LLC (USA)

Xcode Life Sciences (India)

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Direct-to-Consumer (DTC) Genetic Testing Market Share (in %) by Company: 2020 & 2025

Market Analytics

CANADA

JAPAN

CHINA

EUROPE

Market Facts & Figures

European Direct-to-Consumer (DTC) Genetic Testing Market: Competitor Market Share Scenario (in %) for 2020 & 2025

Market Analytics

FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC

AUSTRALIA

INDIA

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION

Total Companies Profiled: 84

Note: Product cover images may vary from those shown
Adroll
adroll